These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11889961)

  • 1. Repolarization and refractoriness in patients with persistent atrial fibrillation.
    Santini M; Pandozi C
    Ann Ist Super Sanita; 2001; 37(3):435-41. PubMed ID: 11889961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relations between monophasic action potential duration and refractoriness after cardioversion of persistent atrial fibrillation: results in wash-out and amiodarone-treated patients.
    Pandozi C; Gentilucci G; Calò L; Castro A; Lamberti F; Loricchio ML; Santini L; Magris B; Bulava A; Peichl P; Santini M
    Ital Heart J; 2003 Apr; 4(4):257-63. PubMed ID: 12784779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrophysiologic characteristics of the atrium during chronic atrial fibrillation in man].
    Pandozi C; Bianconi L; Villani M; Castro A; Toscano S; Altamura G; Jesi AP; Auriti A; Gentilucci G; Magris B; Santini M
    G Ital Cardiol; 1997 Mar; 27(3):270-7. PubMed ID: 9244729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of successful cardioversion of persistent atrial fibrillation on right ventricular refractoriness and repolarization.
    Manios EG; Kallergis EM; Kanoupakis EM; Mavrakis HE; Mouloudi HK; Klapsinos NK; Vardas PE
    Europace; 2005 Jan; 7(1):34-9. PubMed ID: 15670965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal changes in atrial refractoriness following DC cardioversion of persistent atrial fibrillation in man.
    Spurrell P; Kamalvand K; Higson M; Sulke N
    Europace; 2004 May; 6(3):229-35. PubMed ID: 15121076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of IKr blocker nifekalant on atrial action potential duration after successful internal cardioversion of chronic atrial fibrillation.
    Kofune T; Watanabe I; Okubo K; Okumura Y; Masaki R; Shindo A; Saito S
    Pacing Clin Electrophysiol; 2005 May; 28(5):391-6. PubMed ID: 15869670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence.
    Osaka T; Yamazaki M; Yokoyama E; Ito A; Kodama I
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):877-84. PubMed ID: 15333078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation and effective refractory period of the pulmonary vein ostia.
    Adragão P; Santos KR; Aguiar C; Neves JP; Abecassis M; Cavaco D; Morgado F; Bernardo R; Bonhorst D; Queiroz e Melo J; Seabra-Gomes R
    Rev Port Cardiol; 2002 Oct; 21(10):1125-34. PubMed ID: 12522975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of 5-HT4 receptor blockade and stimulation, during six hours of atrial fibrillation.
    Leftheriotis DI; Theodorakis GN; Poulis D; Flevari PG; Livanis EG; Iliodromitis EK; Papalois A; Kremastinos DT
    Europace; 2005 Nov; 7(6):560-8. PubMed ID: 16216758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electrophysiological mechanisms of atrial fibrillation].
    Aslan O; Güneri S
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):244-52. PubMed ID: 12223334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
    Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
    Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
    Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias.
    Haïssaguerre M; Hocini M; Sanders P; Sacher F; Rotter M; Takahashi Y; Rostock T; Hsu LF; Bordachar P; Reuter S; Roudaut R; Clémenty J; Jaïs P
    J Cardiovasc Electrophysiol; 2005 Nov; 16(11):1138-47. PubMed ID: 16302893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of propensity to atrial fibrillation in patients undergoing isthmus ablation for typical atrial flutter.
    Ramanna H; De Bakker JM; Hauer RN
    J Cardiovasc Electrophysiol; 2005 Feb; 16(2):167-72. PubMed ID: 15720455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced dispersion of atrial refractoriness as an electrophysiological substrate for vulnerability to atrial fibrillation in patients with paroxysmal atrial fibrillation.
    Oliveira MM; da Silva N; Timóteo AT; Feliciano J; de Sousa L; Santos S; Marques F; Ferreira R
    Rev Port Cardiol; 2007; 26(7-8):691-702. PubMed ID: 17939579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of electrical remodeling after cardioversion of persistent atrial fibrillation.
    Raitt MH; Kusumoto W; Giraud G; McAnulty JH
    J Cardiovasc Electrophysiol; 2004 May; 15(5):507-12. PubMed ID: 15149416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AVE0118, blocker of the transient outward current (I(to)) and ultrarapid delayed rectifier current (I(Kur)), fully restores atrial contractility after cardioversion of atrial fibrillation in the goat.
    de Haan S; Greiser M; Harks E; Blaauw Y; van Hunnik A; Verheule S; Allessie M; Schotten U
    Circulation; 2006 Sep; 114(12):1234-42. PubMed ID: 16940189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
    Eijsbouts S; Ausma J; Blaauw Y; Schotten U; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):648-54. PubMed ID: 16836716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dispersion of refractoriness in patients with paroxysmal atrial fibrillation. Evaluation with simultaneous endocardial recordings from both atria.
    Li Z; Hertervig E; Carlson J; Johansson C; Olsson SB; Yuan S
    J Electrocardiol; 2002 Jul; 35(3):227-34. PubMed ID: 12122613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
    Wozakowska-Kapłon B; Opolski G
    Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.